Condition: Atrial Fibrillation · Atrial Flutter · Atrial Arrhythmia · Sponsor: LUMA Vision Ltd.
The objective of the study is to collect data on the use of the VERAFEYE Anatomical Guidance System in adult patients indicated to undergo a catheter ablation procedure for the treatment of Atrial Flutter (AFL), paroxysmal AF (PAF) or persistent AF (perAF). The study will collect specific information on management of AFL/AF ablation procedures with the commercial VERAFEYE Anatomical Guidance System including but not limited to acute procedural success , and how the VERAFEYE Anatomical Guidance System is used overall. Results from this study may be used to guide development and refinement the VERAFEYE Anatomical Guidance System.
This description comes directly from the study's public registry record.
Alisa Komleva · 0894352047 · alisa.komleva@lumavision.com
Elke Sommerijns · +32 479 76 71 56 · Elke.sommerijns@lumavision.com
Always discuss trial participation with your own doctor first.
| Klinicki Bolnicki Centar (KBC) | Split, Croatia | Not Yet Recruiting |
| Na Homolce Hospital | Prague, Czechia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07210151